Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,913,366
-$373,959 QoQ
Shares Held
120,987
+3.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#810
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. PFE ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
This page
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,913,366 | 120,987 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,287,325 | 117,070 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,156,423 | 126,764 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,089,144 | 121,238 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,833,995 | 116,914 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,305,078 | 90,966 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,929,208 | 72,718 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,093,751 | 72,348 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,955,578 | 69,892 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,899,903 | 68,465 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,336,510 | 81,157 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,502,387 | 105,589 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,062,896 | 110,766 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $4,255,480 | 104,301 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,092,948 | 79,878 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,596,021 | 82,176 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,223,341 | 80,552 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $4,142,324 | 80,014 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,636,724 | 78,522 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,302,823 | 76,792 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,916,049 | 74,465 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $2,231,043 | 61,580 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,616,584 | 43,917 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,469,650 | 40,045 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,073,999 | 32,844 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $860,911 | 26,376 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||